FR2762213B1 - PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION - Google Patents

PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION

Info

Publication number
FR2762213B1
FR2762213B1 FR9704803A FR9704803A FR2762213B1 FR 2762213 B1 FR2762213 B1 FR 2762213B1 FR 9704803 A FR9704803 A FR 9704803A FR 9704803 A FR9704803 A FR 9704803A FR 2762213 B1 FR2762213 B1 FR 2762213B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
gastric retention
gastric
retention
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9704803A
Other languages
French (fr)
Other versions
FR2762213A1 (en
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9704803A priority Critical patent/FR2762213B1/en
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to JP54514398A priority patent/JP2001523241A/en
Priority to PCT/FR1998/000755 priority patent/WO1998047506A1/en
Priority to AU73416/98A priority patent/AU737634B2/en
Priority to IL13199598A priority patent/IL131995A0/en
Priority to NZ500288A priority patent/NZ500288A/en
Priority to HU0002455A priority patent/HUP0002455A3/en
Priority to EP98920623A priority patent/EP0983065A1/en
Priority to CN98804269A priority patent/CN1252720A/en
Priority to KR1019997009438A priority patent/KR20010006353A/en
Priority to PL98336273A priority patent/PL336273A1/en
Priority to CA002286081A priority patent/CA2286081A1/en
Priority to TNTNSN98049A priority patent/TNSN98049A1/en
Priority to PE1998000281A priority patent/PE68199A1/en
Priority to MA25037A priority patent/MA26482A1/en
Priority to ARP980101773A priority patent/AR015586A1/en
Priority to ZA983258A priority patent/ZA983258B/en
Priority to JO19982017A priority patent/JO2017B1/en
Publication of FR2762213A1 publication Critical patent/FR2762213A1/en
Publication of FR2762213B1 publication Critical patent/FR2762213B1/en
Application granted granted Critical
Priority to NO995039A priority patent/NO995039L/en
Priority to US09/886,991 priority patent/US20010046473A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9704803A 1997-04-18 1997-04-18 PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION Expired - Fee Related FR2762213B1 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (en) 1997-04-18 1997-04-18 PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION
CA002286081A CA2286081A1 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition
PCT/FR1998/000755 WO1998047506A1 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition
AU73416/98A AU737634B2 (en) 1997-04-18 1998-04-15 Pharmaceutical composition for gastric residence
IL13199598A IL131995A0 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical compositions
NZ500288A NZ500288A (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition comprising benzamide as the active principle and a carbon dioxide generating system
HU0002455A HUP0002455A3 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition
EP98920623A EP0983065A1 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition
CN98804269A CN1252720A (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical compositions
KR1019997009438A KR20010006353A (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition
JP54514398A JP2001523241A (en) 1997-04-18 1998-04-15 Gastric retention pharmaceutical composition
PL98336273A PL336273A1 (en) 1997-04-18 1998-04-15 Pharmaceutic composition active in stomach portion of gastrointestinal system
TNTNSN98049A TNSN98049A1 (en) 1997-04-18 1998-04-16 PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE.
MA25037A MA26482A1 (en) 1997-04-18 1998-04-17 PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE.
ARP980101773A AR015586A1 (en) 1997-04-18 1998-04-17 PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE.
ZA983258A ZA983258B (en) 1997-04-18 1998-04-17 Pharmaceutical composition for gastric residence
PE1998000281A PE68199A1 (en) 1997-04-18 1998-04-17 PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE
JO19982017A JO2017B1 (en) 1997-04-18 1998-04-18 Pharmaceutical-composition for gastric residence
NO995039A NO995039L (en) 1997-04-18 1999-10-15 Gastric retained pharmaceutical preparation
US09/886,991 US20010046473A1 (en) 1997-04-18 2001-06-25 Gastric-retained pharmaceutical composition and method for its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (en) 1997-04-18 1997-04-18 PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION

Publications (2)

Publication Number Publication Date
FR2762213A1 FR2762213A1 (en) 1998-10-23
FR2762213B1 true FR2762213B1 (en) 1999-05-14

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9704803A Expired - Fee Related FR2762213B1 (en) 1997-04-18 1997-04-18 PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION

Country Status (19)

Country Link
EP (1) EP0983065A1 (en)
JP (1) JP2001523241A (en)
KR (1) KR20010006353A (en)
CN (1) CN1252720A (en)
AR (1) AR015586A1 (en)
AU (1) AU737634B2 (en)
CA (1) CA2286081A1 (en)
FR (1) FR2762213B1 (en)
HU (1) HUP0002455A3 (en)
IL (1) IL131995A0 (en)
JO (1) JO2017B1 (en)
MA (1) MA26482A1 (en)
NO (1) NO995039L (en)
NZ (1) NZ500288A (en)
PE (1) PE68199A1 (en)
PL (1) PL336273A1 (en)
TN (1) TNSN98049A1 (en)
WO (1) WO1998047506A1 (en)
ZA (1) ZA983258B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (en) 1998-10-16 2002-01-25 Synthelabo PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE AND CONTROLLED RELEASE
FR2790388B1 (en) * 1999-03-04 2001-04-13 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZAMIDE AND AT LEAST ONE ABSORPTION PROMOTER
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2009157711A2 (en) * 2008-06-24 2009-12-30 Park Eun-Seok Gastro-retentive porous tablet and method for preparing same
FR2949061B1 (en) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma FLOATING MICROGRANULES
SI2719376T1 (en) 2012-10-12 2015-06-30 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
JP7044649B2 (en) * 2018-06-28 2022-03-30 株式会社ファンケル Intragastric floating tablets
KR20220018004A (en) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 Controlled release formulations and uses thereof
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (en) * 1978-01-20 1979-08-17 Ile De France NEW DERIVATIVES OF 4-AMINO-5-ALKYLSULFONYL ORTHO-ANISAMIDES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS PSYCHOTROPES
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
JPS62178518A (en) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk Novel long-acting sulpiride tablet
JPH0776172B2 (en) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 Matrice locks
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials

Also Published As

Publication number Publication date
AU737634B2 (en) 2001-08-23
PL336273A1 (en) 2000-06-19
NZ500288A (en) 2001-03-30
AR015586A1 (en) 2001-05-16
FR2762213A1 (en) 1998-10-23
AU7341698A (en) 1998-11-13
NO995039D0 (en) 1999-10-15
NO995039L (en) 1999-12-17
HUP0002455A3 (en) 2001-01-29
WO1998047506A1 (en) 1998-10-29
MA26482A1 (en) 2004-12-20
JO2017B1 (en) 1999-05-15
TNSN98049A1 (en) 2005-03-15
PE68199A1 (en) 1999-07-15
CN1252720A (en) 2000-05-10
KR20010006353A (en) 2001-01-26
EP0983065A1 (en) 2000-03-08
IL131995A0 (en) 2001-03-19
JP2001523241A (en) 2001-11-20
HUP0002455A2 (en) 2000-12-28
ZA983258B (en) 1998-10-19
CA2286081A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
IS4974A (en) Pressure-spray pharmaceutical composition
EE200000098A (en) A pharmaceutical composition for combining piperidinoalkanol decongestant
ID23874A (en) DRUG
DK0783302T3 (en) drugs
FI973243A (en) A new pharmaceutical combination
NO20004345L (en) Pharmaceutical composition
BRPI9810519B1 (en) 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
NO994003L (en) Pharmaceutical mixture
DK1017392T3 (en) Medicines
FR2762213B1 (en) PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION
EE9900545A (en) A pharmaceutical composition
BR9600809A (en) Medication
BR9508339A (en) Medication
NO994619D0 (en) Pharmaceutical mixtures
LV11727A (en) Pharmaceutical composition
MA26531A1 (en) PHARMACEUTICAL COMPOSITION
ID25857A (en) PHARMACEUTICAL COMPOSITION
FI955605A0 (en) Aryling drug
FI973280A (en) Pharmaceutical composition
BR9605777A (en) Pharmaceutical composition
NO964309D0 (en) Pharmaceutical composition
FR2772264B1 (en) PILL
ID21180A (en) PHARMACEUTICAL COMPOUNDS
FI3163U1 (en) Pharmaceutical Containers
FI3862U1 (en) Gel-shaped pharmaceutical preparation

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse